Results 51 to 60 of about 1,873 (99)

Nexus of Whey Proteins, Gut Dysbiosis, and Colonic Health

Food Science &Nutrition, Volume 14, Issue 2, February 2026.
Whey proteins possess antimicrobial and prebiotic properties that modulate gut microbiota by promoting beneficial bacteria like Bifidobacterium while suppressing pathogens. This modulation enhances short‐chain fatty acid production and strengthens intestinal barrier integrity, potentially alleviating dysbiosis‐related conditions such as colitis and ...
Tolulope Joshua Ashaolu, Chi‐Ching Lee, Ozgur Tarhan, Ali Rashidinejad, Seid Mahdi Jafari   +4 more
wiley   +1 more source

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease [PDF]

, 2009
SummaryA high-fat diet (HFD) induces metabolic disease and low-grade metabolic inflammation in response to changes in the intestinal microbiota through as-yet-unknown mechanisms.
Garidou, Lucile, Pomié, Céline, Klopp, Pascale, Waget, Aurélie, Charpentier, Julie, Aloulou, Meryem, Giry, Anaïs, Serino, Matteo, Stenman, Lotta, Lahtinen, Sampo, Dray, Cedric, Iacovoni, Jason S., Courtney, Michael, Collet, Xavier, Amar, Jacques, Servant, Florence, Lelouvier, Benjamin, Valet, Philippe, Eberl, Gérard, Fazilleau, Nicolas, Douin-Echinard, Victorine, Heymes, Christophe, Burcelin, Rémy   +22 more
core   +3 more sources

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Advanced Healthcare Materials, Volume 15, Issue 1, 9 January 2026.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro   +12 more
wiley   +1 more source

The microbiota–gut–brain axis in mild cognitive impairment and Alzheimer's disease: a scoping review of human studies

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract Alzheimer's disease (AD) is projected to become the highest‐burden neurological disorder globally. Mounting evidence implicates the gut microbiome in AD pathogenesis. This scoping review of gut microbiomes in mild cognitive impairment (MCI) and AD included dietary and probiotic interventions.
Alison Warren, Zan Wynia, Patrick G. Corr, Mershad Fahim Devin, Zeynep Celikkol, Lindsey Gordon, Mina Farah, Michaela Karam, Daniel Villarreal, Scott A. Jackson, Leigh A. Frame   +10 more
wiley   +1 more source

Alpha‐Ketoglutarate Regulates Intestinal Motility and Health by OXGR1 in Nitrergic Neuron of Enteric Nervous System

Food Frontiers, Volume 7, Issue 1, January 2026.
ABSTRACT Intestinal health could be affected by intestinal motility, which is controlled by the enteric nervous system. In this study, we found that α‐ketoglutarate (AKG) inhibits intestinal motility and improves intestinal permeability, accompanied by an increased count of intestinal flora.
Guli Xu, Jingjing Zhou, Pingwen Xu, Ishwari Gyawali, Chang Xu, Jinping Yang, Zewei Ma, Dan Du, Qingyan Jiang, Gang Shu   +9 more
wiley   +1 more source

As-yet-uncultivated oral bacteria: breadth and association with oral and extra-oral diseases [PDF]

, 2013
It has been shown that 40–60% of the bacteria found in different healthy and diseased oral sites still remain to be grown in vitro, phenotypically characterized, and formally named as species.
Aas JA, Dymock D, Gibbons RJ, Hugenholtz P, Isabela N. Rôças, José F. Siqueira Jr, Koch AL, Marcy Y, Marsh P, Miller WD, Suau A, Vartoukian SR, Wade W, Wyss C   +13 more
core   +1 more source

Fuc‐S, a New Degraded Polysaccharide From Fucoidan, Alleviates Type 2 Diabetes‐Associated Liver Injury Through Modulating Gut Microbiota

Food Science &Nutrition, Volume 14, Issue 1, January 2026.
Fuc‐S alleviated type 2 diabetes‐associated liver injury through gut microbiota‐SCFA‐liver axis regulation. Fuc‐S treatment significantly improved glucose tolerance, lipid metabolism, and liver function, while reducing hepatic steatosis and serum ALT/AST levels. Fuc‐S reinforced intestinal barrier integrity by upregulating tight junction proteins (ZO‐1
Bin Du, Caihong Cheng, Jinxiu Feng, Yue Liang, Wang Tao, Baojun Xu, Jiao Peng, Guangtao Zhang, Yuedong Yang   +8 more
wiley   +1 more source

Microbiota analysis of environmental slurry and its potential role as a reservoir of bovine digital dermatitis pathogens [PDF]

, 2017
At present, very little information exists regarding what role the environmental slurry may play as an infection reservoir and/or route of transmission for bovine digital dermatitis (DD), a disease which is a global problem in dairy herds. To investigate
Isbrand, Anastasia, Jensen, Tim Kåre, Schou, Kirstine Klitgaard, Strube, Mikael Lenz, Weiss Nielsen , Martin   +4 more
core   +1 more source

Impact of a GABA‐Producing Lactococcus lactis on Microbiota and Mycobiota During CNS Inflammatory Demyelination

FASEB BioAdvances, Volume 8, Issue 1, January 2026.
GABA‐producing Lactococcus lactis protects against experimental autoimmune encephalomyelitis (EAE) in a mouse source‐dependent manner. The study focuses on the therapeutic potential of genetically engineered gamma‐aminobutyric acid (GABA)‐overproducing Lactococcus lactis (P8s‐GAD L. lactis) in the EAE model.
Kristina Hill, Alexandra LaFollette, Trevor O. Kirby, Soledad Negrete, Dani Babcock, Kari Felton, Hannah Kohl, Kavita Sharma, Andrea Castillo, Jean‐Baptiste Roullet, K. Michael Gibson, Javier Ochoa‐Repáraz   +11 more
wiley   +1 more source

A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction

Neurogastroenterology &Motility, Volume 38, Issue 1, January 2026.
The pathophysiology of functional dyspepsia and irritable bowel syndrome includes altered motility, secretion, sensitivity to sensory signals, impaired epithelial barrier function, inflammation, and gut dysbiosis. The phytomedicine, STW 5‐II, represents a multi‐targeted approach, addressing these pathophysiologies.
Anita Annaházi, Rudolf Bauer, Thomas Efferth, Mohamed T. Khayyal, Michael Schemann, Gudrun Ulrich‐Merzenich, Christine Feinle‐Bisset   +6 more
wiley   +1 more source